| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |